1) MDR
多药抗药（MDR）
2) multiple
多药
1.
Chemoprotective role of multiple drug resistance gene over expression in human bone marrow CD34~+ cells;
多药耐药基因在人骨髓CD34~+细胞中的表达及对化疗药物的耐受性
2.
Relationship between expression of pS2, ER, PR, c-erbB-2 and multiple drug resistance in breast cancer;
乳腺浸润性导管癌pS2基因、ER、PR、c-erbB-2与多药耐药基因表达及临床指标的相关性
3.
Objective: To evaluate the feasibility of gene therapy using Zinc ribbon domaincontaining 1 (ZNRD1) as target for multiple drug resistance of leukemia.
目的:探讨转录相关锌带蛋白基因(zincribbondomaincontaining1protein,ZNRD1)作为靶分子进行白血病多药耐药基因治疗的可行性。
3) Multidrug
多药
1.
Reversal of multidrug resistance of K562/A02 cell line by mdr1 and GSTπ gene silence;
mdr1和GSTπ基因缄默逆转K562/A02细胞多药耐药性的研究
2.
Progress in the study for mechanisms of multidrug resistance in breast cancer;
乳腺癌多药耐药机制研究进展
3.
OBJECTIVE: To evaluate the relationship between the clinical stages of nasopharyngeal carcinoma (NPC) and the expression of multidrug resistance-associated protein (MRP).
目的:探讨多药耐药相关蛋白(mul-tidrugresistance-associatedprotein,MRP)在鼻咽癌中的表达及与临床分期的关系。
4) multidrug resistance
多药耐药
1.
Function and mechanism of Baihua Sheshecao Injection reversing multidrug resistance of K562/ADM cells;
白花蛇舌草注射液逆转K562/ADM细胞多药耐药的作用和机制
2.
In Vitro study of the effect of cyclosporine A,tetrandrine and their combination on the reversion of multidrug resistance in leukemia cell line;
环孢菌素A、汉防己甲素及两者联合逆转K562/A02细胞的多药耐药
3.
Reversal of multidrug resistance of hepatocellular carcinoma by siRNA/mdr1;
RNA干扰逆转肝细胞癌多药耐药
5) multi-drug resistant
耐多药
1.
Fiberoptic bronchoscopic interventional therapy of multi-drug resistant caseous tuberculous pneumonia with gel containing drugs;
含药凝胶经纤维支气管镜介入治疗耐多药结核性干酪性肺炎
2.
Efficacy of freeze-dried M. vaccae vaccine in treatment of patients with multi-drug resistant pulmonary tuberculosis;
冻干治疗用母牛分支杆菌菌苗对耐多药肺结核患者临床疗效及细胞免疫功能的影响
3.
Experience in treating 86 patients with multi-drug resistant pulmonary tuberculosis by used ALP ( amikacin, levofloxacin, sodium, aminosalicylate ) regimen;
ALP方案治疗86例耐多药结核病的疗效分析
6) Multi-drug resistance
多药耐药
1.
The research of CIK cells reverse multi-drug resistance in vitro;
CIK细胞体外逆转多药耐药性的研究
2.
Relation between multi-drug resistance and apoptosis of HepG2/5-Fu;
人肝癌HepG2/5-Fu耐药细胞株多药耐药与凋亡关系的研究
3.
Expression of glutathione S-transferase π and multi-drug resistance associated protein in squamous cell carcinoma tissue;
皮肤鳞状细胞癌组织中谷胱甘肽-S-转移酶和多药耐药相关蛋白的表达
参考词条
补充资料：抗休克药
分子式：
CAS号：
性质：是一类用于治疗休克的药物。按病因和病理生理特点分为低血容量性、感染性、心原性、过敏性、神经原性休克等类型。抗休克治疗涉及非常广泛的药物。主要有:血管扩张药、血管收缩药、降低心肌耗氧量的药物、增强心肌收缩力的药物、糖皮质激素类、纠正代谢紊乱的药物、防止弥散性血管内凝血发生的药物等。此外，还有针对休克病因的治疗药物。
CAS号：
性质：是一类用于治疗休克的药物。按病因和病理生理特点分为低血容量性、感染性、心原性、过敏性、神经原性休克等类型。抗休克治疗涉及非常广泛的药物。主要有:血管扩张药、血管收缩药、降低心肌耗氧量的药物、增强心肌收缩力的药物、糖皮质激素类、纠正代谢紊乱的药物、防止弥散性血管内凝血发生的药物等。此外，还有针对休克病因的治疗药物。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。